LifeMD, Inc.
Company Stats
- Market Cap
- $139.8M
- as of Sep 30, 2026
- Shares Outstanding
- 48.2M
- Free Float
- 79.7%
Income Statement
- Revenue
- $194.1M
- Operating Income
- -$7.7M
- Net Income
- $14.4M
- EBITDA
- -$6.8M
- Revenue Growth, 3Y
- 17.7%
- FCF Margin, 3Y Avg
- 6.4%
- FCF Margin, Worst Year
- 3.3%
Cash Flow
- Free Cash Flow
- $6.4M
- FCF Yield
- 4.6%
- Owner FCF Yield
- -2.9%
Returns & Capital
- Dividends Paid
- $3.1M
- Dividend Yield
- 2.2%
- Share Repurchases
- $270,000
- SBC, 3Y Avg
- $11.7M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $194.1M | $6.4M | 3.3% |
| FY2024 | $154.8M | $16.0M | 10.4% |
| FY2023 | $152.5M | $8.6M | 5.6% |
| FY2022 | $119.0M | -$23.3M | -19.6% |
| FY2021 | $92.9M | -$33.3M | -35.9% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 26, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back
GLP-1 Shift: Branded Access and Oral Formulations Gain Ground